Found 5 matching trials
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma PHASE2 To evaluate the clinical efficacy of perioperative treatment with S-1 + oxa...
Show More Location
Chiba Cancer Center
Learn More & Join Trial
Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma PHASE2 This Phase II clinical study is a prospective, open-label, single-arm trial...
Show More Location
The First Hospital of Nanjing Medical University
Learn More & Join Trial
Neoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ Adenocarcinoma NA This study is a prospective, open-label, multicenter, randomized controlled...
Show More Location
Tongji Hospital, Huazhong University of Science and Technology
Learn More & Join Trial
HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer PHASE2 Patients with locally advanced gastric cancer (LAGC), particularly those wi...
Show More Location
Multiple Locations
Learn More & Join Trial